Innovation Pharmaceuticals, based in Beverly, MA, is a publicly traded clinical stage biopharmaceutical company focused on developing innovative therapies to combat infectious diseases and address areas of unmet medical need.
The company's lead drug candidate, Brilacidin, exhibits broad-spectrum antimicrobial properties and has been granted Fast Track designation for its potential in treating oral mucositis, a common side effect of chemoradiation treatment.
Generated from the website